hotspot -WSS

hotspot

author：focus 2025-10-01 13:58:23 - browse：77588

the Federal Trade Commission building and its brown sign — Adobe

A federal judge ordered Wednesday that Novant Health can move forward with its plan to buy two North Carolina hospitals, denying the Federal Trade Commission’s request for an injunction.

The FTC sued to block the deal in January, arguing that it would give Novant control of more than 65% of the region’s inpatient market. The case, one seeking to block nearby hospitals from merging and creating an even more powerful dominant player, is the FTC’s bread and butter. The agency has shied away from challenging cross-market and vertical mergers, but this one is right in its wheelhouse, which makes the setback surprising.

Under the deal, announced early last year, Novant would buy two hospitals in the same county from for-profit Community Health Systems for $320 million. The hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only a 25-minute drive from one another. Davis Regional used to be a full-service hospital, but is now a psychiatric hospital. The deal also includes a group of 24 doctors, a majority interest in an endoscopy center, and a holding in a planned surgery center.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Wikipedia

WSS

Generate Biomedicines machine learning biotech raises $273M

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Ventyx halts psoriasis drug development after lackluster trial results

First transplant of an entire human eye performed

Regeneron agrees to White House price limits on anti

Will the IRA bring competition to the biologics market?

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

23andMe had bad news about my health. I wish a person had delivered it

New weight loss drugs vying to be the next Wegovy or Mounjaro

Affirmative action in medical school literally saved lives

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Virginia high school admissions case could be legal follow

Food makers to regulators: Ultra

In age of alternative facts, a scholarly course on calling out crap

Study suggests Covid rebound is far more common with Paxlovid than without

Jerome Adams on the need for new antivirals for Covid

Diverse clinical trials: Why aren’t we there yet?

hotspot

Hospitals consider fixing cancer drug shortages on their own

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Acelyrin, a rare IPO success, stumbles in its first big test

A common UTI test for kids haunts adults as a traumatic 'nightmare'

How housing is health care on Long Island

What to make of Biden’s latest efforts on cancer research

Wikipedia

leisure time

entertainment

hotspot